Adjuvant imatinib mesylate increases recurrence free survival (RFS) in patients with completely resected localized primary gastrointestinal stromal tumor (GIST): North American Intergroup Phase III trial ACOSOG Z9001
- Citation:
- ASCO Annual Meeting Oral abstract
- Meeting Instance:
- ASCO 2007
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 268
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- R. Dematteo K. Owzar R. Maki P. Pisters M. Blackstein C. Antonescu C. Blanke G. Demetri M. Von Mehren K. Ballman
- Networks:
- Study
- ACOSOG-Z9001
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: